Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease.

Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Abstract Text:

Seigo Sugiyama,Hironobu Fukushima,Kiyotaka Kugiyama,Hidetomo Maruyoshi,Sunao Kojima,Tohru Funahashi,Tomohiro Sakamoto,Yoko Horibata,Keisuke Watanabe,Hidenobu Koga,Koichi Sugamura,Fumiyuki Otsuka,Iichirou Shimomura,Hisao Ogawa,Seigo Sugiyama,Hironobu Fukushima,Kiyotaka Kugiyama,Hidetomo Maruyoshi,Sunao Kojima,Tohru Funahashi,Tomohiro Sakamoto,Yoko Horibata,Keisuke Watanabe,Hidenobu Koga,Koichi Sugamura,Fumiyuki Otsuka,Iichirou Shimomura,Hisao Ogawa,

Reduced incidence of type-2 diabetes has been shown in patients treated with pravastatin. Adiponectin can exhibit beneficial effects on glucose metabolism. We investigated whether pravastatin could improve glucose tolerance associated with increasing adiponectin levels in patients with impaired glucose tolerance (IGT). This study consisted of 40 coronary artery disease (CAD) patients with IGT assessed by oral glucose tolerance test (OGTT). Patients were randomized to receive pravastatin (n=20) or no lipid-lowering medications (control group, n=20) for 6 months, after which OGTT was repeated and adiponectin levels were measured. Pravastatin treatment significantly decreased levels of total cholesterol (16%), low-density lipoprotein cholesterol (23%) and high-sensitivity C-reactive protein (37%) (p<0.01, respectively). At 2h in OGTT, pravastatin significantly improved hyperglycemia (-14%) and hyperinsulinemia (-23%). Pravastatin treatment significantly elevated plasma adiponectin levels (35%; p<0.001) but not in the control group. The glucose reduction at 2h post-OGTT was significantly associated with increased levels of adiponectin (r=-0.462; p=0.003). Pravastatin treatment is an independent predictor for improvement of post-loaded hyperglycemia (odds ratio; 5.7; 95% confidence interval 1.7-19.3; p=0.003) and achieved beneficial conversion from IGT to normal glucose tolerance (40%; p=0.03). Pravastatin exhibits beneficial effects on glucose metabolism especially in the postprandial state associated with increasing plasma adiponectin levels in CAD patients with IGT.

Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Publishing Authors By Initials

S Sugiyama,H Fukushima,K Kugiyama,H Maruyoshi,S Kojima,T Funahashi,T Sakamoto,Y Horibata,K Watanabe,H Koga,K Sugamura,F Otsuka,I Shimomura,H Ogawa,S Sugiyama,H Fukushima,K Kugiyama,H Maruyoshi,S Kojima,T Funahashi,T Sakamoto,Y Horibata,K Watanabe,H Koga,K Sugamura,F Otsuka,I Shimomura,H Ogawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Atherosclerosis

VOLUME: 194

Page Numbers: e43-51

Journal Abbreviation: Atherosclerosis

ISSN: 0021-9150

DAY: 16

MONTH: 11

YEAR: 2006

Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 242543

Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease.

AFFILIATION: Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, Kumamoto 860-8556, Japan. ssugiyam@kumamoto-u.ac.jp

Country: Ireland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Atherosclerosis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease Related Publications

• A role for proteoglycans in mineralized tissue-titanium adhesion.
• A simple and rapid method for cryopreservation of mouse 2-cell embryos by vitrification: Beneficial effect of sucrose and raffinose on their cryosurvival rate.
• Accumulation and fate of green fluorescent labeled Escherichia coli in laboratory-scale drinking water biofilters.
• An efficient method for sonication assisted Agrobacterium-mediated transformation of coat protein (CP) coding genes into papaya (Carica papaya L.).
• An fMRI study of the functional distinction of neuronal circuits at the sites on ventral visual stream co-activated by visual stimuli of different objects.
• Cardiac cell therapy and arrhythmias.
• Changing concepts of bladder regeneration.
• Detection and identification of Brettanomyces/Dekkera sp. yeasts with a loop-mediated isothermal amplification method.
• Do children with tuberous sclerosis complex have superior musical skill?--A unique tendency of musical responsiveness in children with TSC.
• From gene networks underlying sex determination and gonadal differentiation to the development of neural networks regulating sociosexual behavior.
• Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.
• Glycosaminoglycan degradation reduces mineralized tissue-titanium interfacial strength.
• Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties.
• Hypoxia-mediated induction of heme oxygenase type I and carbon monoxide release from astrocytes protects nearby cerebral neurons from hypoxia-mediated apoptosis.
• Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening.
• Impacts of diclidophorid monogenean infections on fisheries in Japan.
• Incorporating electron-transfer functionality into synthetic metalloproteins from the bottom-up.
• Interaction between p21-activated protein kinase and Rac during differentiation of HL-60 human promyelocytic leukemia cell induced by all-trans-retinoic acid.
• Meiotic recombination-related DNA synthesis and its implications for cross-over and non-cross-over recombinant formation.
• Osteoinduction by recombinant human bone morphogenetic protein-2 in muscles of non-human primates.
• Oxalate synthesis from hydroxypyruvate in vitamin-B6-deficient rats.
• P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.
• Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.
• Production of functional spermatids from mouse germline stem cells in ectopically reconstituted seminiferous tubules.
• Production of normal piglets from microsurgically split morulae and blastocysts.
• Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome.
• Solitary upper ureteral malakoplakia successfully diagnosed by ureteroscopic biopsy and treated conservatively.
• Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity.
• The survival of whole and bisected rabbit morulae after cryopreservation by the vitrification method.
• Ventricular septal rupture masquerading as coronary perforation during intervention for acute myocardial infarction.